Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Q4 2023 Portfolio Holders as of 12/31/2023

Type / Class
Equity / COMMON STOCK
Number of holders
40
Total Shares
14.9M
Shares change
+202K
Total reported value, excl. options
$73.1M
Value change
+$986K
Put/Call ratio
0
Number of buys
18
Number of sells
-13
Price
$4.92
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.